Rodilo SRL
The score of Rodilo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rodilo's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
Rodilo's financial analysis
- Solvency-43.9%sector median: 42.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rodilo
Rodilo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0801.891.476
- VAT number
- BE0801891476
- Peppol
- Registered · 0208:0801891476 · as of 05 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 May 2023
- Registered office
- 4000 Liège
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Rodilo (SRL) has been based in Liège since 2023, active in: manufacture of medicaments. For 2025, it reports a net loss of 50,210 € and equity of −89,783 €; its revenue is not published. Its solvency stands at -43.9%, below the median of its sector (42.6%).
Companies similar to Rodilo
Companies in the same business, of comparable size and area, outside its group.
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Flindr Labs Manufacture of pharmaceutical preparations Ghent · balance sheet 262,929 €
- SpectronRx Europe Manufacture of basic pharmaceutical products Grimbergen · balance sheet 198,933 €
- XeroThera Europe Manufacture of basic pharmaceutical products Liège · balance sheet 820,359 €
- Pharma Chemicals France Manufacture of basic pharmaceutical products Braine-le-Château · balance sheet €1.08m
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
- Intibio Manufacture of pharmaceutical preparations Bree · balance sheet 407,778 €
- Harika Lifij Manufacture of basic pharmaceutical products Evere · balance sheet 105,370 €
Frequently asked questions about Rodilo
What is the revenue of Rodilo?
Rodilo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rodilo?
In Belgium, the VAT number is the company number prefixed with BE: BE0801891476 for Rodilo, if the company is VAT-registered. Its company number (CBE) is 0801.891.476.
Where is the registered office of Rodilo?
According to the CBE register, the registered office of Rodilo is in 4000 Liège.
What is the equity of Rodilo?
At the close of the 2025 financial year, the equity of Rodilo amounts to -89,783 €, a solvency of -43.9% of total assets.
Who manages Rodilo?
The register lists 1 active mandates at Rodilo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rodilo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →